Lena Ho
- Molecular Biology top 2%
- Chromatin Remodeling and Cancer 8
- Genomics and Chromatin Dynamics 6
- Signaling Pathways in Disease 3
- Pharmacology top 1%
- Apelin-related biomedical research 9
- Immunology top 5%
- Immune Cell Function and Interaction 3
- T-cell and B-cell Immunology 3
- Cancer Research top 5%
-
- Nuclear Receptors and Signaling 6
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 5
- Co-authors
- Robert H. CrabtreeJeffrey A. RanishDiana C. HargreavesCigall KadochLaura EliasH. Courtney HodgesBruno ReversadeJehnna L. Ronan
- Journals
- Nature (3 papers)Cell stem cell (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesSingaporeAustralia
In The Last Decade
Lena Ho
37 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 3.7k
- Pathology and Forensic Medicine 699
- Pharmacology 653
- Immunology 700
- Cancer Research 444
Countries citing papers authored by Lena Ho
This map shows the geographic impact of Lena Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Ho more than expected).
Fields of papers citing papers by Lena Ho
This network shows the impact of papers produced by Lena Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Ho. The network helps show where Lena Ho may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lena Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 14 | |
| 3 | 2022 | 34 | |
| 4 | 2022 | 30 | |
| 5 | 2022 | 26 | |
| 6 | 2021 | 64 | |
| 7 | 2020 | 39 | |
| 8 | 2017 | 168 | |
| 9 | 2015 | 145 | |
| 10 | 2015 | 10 | |
| 11 | ELABELA: A Hormone Essential for Heart Development Signals via the Apelin Receptorbreakdown → | 2013 | 377 |
| 12 | Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancybreakdown → | 2013 | 981 |
| 13 | 2011 | 211 | |
| 14 | 2010 | 126 | |
| 15 | Chromatin remodelling during developmentbreakdown → | 2010 | 829 |
| 16 | 2008 | 18 | |
| 17 | 2008 | 17 | |
| 18 | 2007 | 47 | |
| 19 | 2006 | 5 | |
| 20 | 1996 | 8 |
About Lena Ho
Lena Ho is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Immunology, having authored 37 papers that have together received 5.0k indexed citations. Recurring topics across this work include Apelin-related biomedical research (9 papers), Chromatin Remodeling and Cancer (8 papers), Genomics and Chromatin Dynamics (6 papers), Nuclear Receptors and Signaling (6 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers), Immune Cell Function and Interaction (3 papers), Signaling Pathways in Disease (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Molecular Biology (3.7k citations), Pathology and Forensic Medicine (699 citations) and Pharmacology (653 citations). Lena Ho has collaborated with scholars based in United States, Singapore and Australia. Frequent co-authors include Robert H. Crabtree, Jeffrey A. Ranish, Diana C. Hargreaves, Cigall Kadoch, Laura Elias, H. Courtney Hodges, Bruno Reversade, Jehnna L. Ronan, Serene C. Chng and Jing Tian. Their work appears in journals such as Nature, Cell stem cell, Proceedings of the National Academy of Sciences, Developmental Cell and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.